A detailed history of Nikko Asset Management Americas, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 11,865,766 shares of PACB stock, worth $18.6 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
11,865,766
Previous 12,640,561 6.13%
Holding current value
$18.6 Million
Previous $17.3 Million 16.48%
% of portfolio
0.23%
Previous 0.2%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$1.2 - $2.17 $929,754 - $1.68 Million
-774,795 Reduced 6.13%
11,865,766 $20.2 Million
Q2 2024

Aug 09, 2024

SELL
$1.36 - $3.65 $250,000 - $670,957
-183,824 Reduced 1.43%
12,640,561 $17.3 Million
Q1 2024

May 02, 2024

SELL
$3.52 - $9.59 $1.32 Million - $3.61 Million
-375,990 Reduced 2.85%
12,824,385 $48.1 Million
Q4 2023

Feb 08, 2024

SELL
$5.97 - $10.36 $1.48 Million - $2.56 Million
-247,291 Reduced 1.84%
13,200,375 $129 Million
Q3 2023

Nov 09, 2023

SELL
$8.23 - $13.93 $1.66 Million - $2.82 Million
-202,282 Reduced 1.48%
13,447,666 $112 Million
Q2 2023

Aug 14, 2023

SELL
$9.97 - $14.05 $3.55 Million - $5.01 Million
-356,567 Reduced 2.55%
13,649,948 $182 Million
Q1 2023

May 03, 2023

SELL
$7.94 - $12.02 $1.27 Million - $1.92 Million
-159,678 Reduced 1.13%
14,006,515 $162 Million
Q4 2022

Feb 13, 2023

SELL
$5.67 - $11.2 $1.28 Million - $2.53 Million
-225,769 Reduced 1.57%
14,166,193 $116 Million
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $182,654 - $398,307
46,477 Added 0.32%
14,391,962 $84.5 Million
Q2 2022

Aug 04, 2022

BUY
$4.02 - $10.43 $1.3 Million - $3.38 Million
324,280 Added 2.31%
14,345,485 $61 Million
Q1 2022

May 06, 2022

BUY
$8.43 - $20.9 $17.8 Million - $44 Million
2,106,180 Added 17.68%
14,021,205 $128 Million
Q4 2021

Feb 08, 2022

BUY
$19.26 - $30.08 $49.4 Million - $77.2 Million
2,567,023 Added 27.46%
11,915,025 $245 Million
Q3 2021

Nov 09, 2021

BUY
$24.86 - $35.02 $30.5 Million - $42.9 Million
1,225,930 Added 15.09%
9,348,002 $236 Million
Q2 2021

Aug 09, 2021

BUY
$22.3 - $36.02 $64.1 Million - $104 Million
2,874,835 Added 54.79%
8,122,072 $284 Million
Q1 2021

May 03, 2021

BUY
$26.38 - $51.15 $6.02 Million - $11.7 Million
228,099 Added 4.54%
5,247,237 $175 Million
Q4 2020

Feb 11, 2021

BUY
$10.5 - $28.5 $9.48 Million - $25.7 Million
902,585 Added 21.93%
5,019,138 $130 Million
Q3 2020

Nov 02, 2020

BUY
$3.61 - $9.87 $14.9 Million - $40.6 Million
4,116,553 New
4,116,553 $41.2 Million
Q4 2018

Feb 08, 2019

SELL
$3.99 - $7.82 $25,847 - $50,657
-6,478 Closed
0 $0
Q3 2018

Oct 15, 2018

BUY
$3.52 - $5.55 $22,802 - $35,952
6,478 New
6,478 $36,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $353M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.